L'Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, è una struttura ospedaliera ed universitaria regionale di rilievo nazionale e di alta specializzazione con sede a Udine, è classificata come A.R.N.A.S.

During the past decade, Clinica Ematologica - Policlinico Universitario conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Ematologica - Policlinico Universitario" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 38 trials, followed by "Gruppo Italiano Trapianto di Midollo Osseo" with 8 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 5 trials sponsored, "Celgene Corporation" with 1 trials sponsored and "Incyte Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Ematologica - Policlinico Universitario" #1 collaborator was "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator, "Augusta University" with 1 trials as a collaborator, "Azienda Ospedaliero-Universitaria Careggi" with 1 trials as a collaborator, "Azienda Policlinico Umberto I" with 1 trials as a collaborator and "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Ematologica - Policlinico Universitario" are "Chronic Myeloid Leukemia" (5 trials), "Acute Myeloid Leukemia" (4 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Hematologic Diseases" (3 trials) and "Leukemia" (3 trials). Many other conditions were trialed in "Clinica Ematologica - Policlinico Universitario" in a lesser frequency.

Most popular intervention types in "Clinica Ematologica - Policlinico Universitario" are "Drug" (35 trials), "Other" (8 trials), "Procedure" (4 trials), "Behavioral" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nilotinib" (4 trials), "Imatinib" (3 trials), "Lenalidomide" (3 trials), "Cyclophosphamide" (2 trials) and "Eltrombopag" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Ematologica - Policlinico Universitario" are 54 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinica Ematologica - Policlinico Universitario". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Clinica Ematologica - Policlinico Universitario, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Ematologica - Policlinico Universitario, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".